申请人:E.R. Squibb & Sons, Inc.
公开号:EP0161939A2
公开(公告)日:1985-11-21
Arylhydroxamates are provided having the structure
wherein R1 is hydrogen, lower alkyl, aryl, lower alkenyl, cycloalkenyl, aralkyl, or
wherein n is 1 to 4 and X is hydroxy, alkoxy, amino, C1-C4 alkylamino or C1-C4- dialkylamino. R2 is hydrogen or lower alkyl; and R3 is C1-C20-alkyl or C3-C10-alkenyl, aryl, arylalkyl, cycloalkyl, arylalkenyl, lower alkoxy, lower alkenyloxy, arylalkoxy or cycloalkyloxy. These compounds are useful as inhibitors of Δ5-lipoxygenase and as such are useful as antiallergy agents.
芳基羟肟酸酯具有以下结构
其中 R1 是氢、低级烷基、芳基、低级烯基、环烯基、芳烷基,或
其中 n 为 1 至 4,X 为羟基、烷氧基、氨基、C1-C4 烷基氨基或 C1-C4 二烷基氨基。R2 是氢或低级烷基;R3 是 C1-C20 烷基或 C3-C10 烯基、芳基、芳烷基、环烷基、芳烯基、低级烷氧基、低级烯氧基、芳烷氧基或环烷氧基。这些化合物可用作Δ5-脂加氧酶的抑制剂,因此可用作抗过敏剂。